001     155829
005     20230915092342.0
024 7 _ |a 10.1038/s41590-020-00846-5
|2 doi
024 7 _ |a pmid:33288963
|2 pmid
024 7 _ |a 1529-2908
|2 ISSN
024 7 _ |a 1529-2916
|2 ISSN
037 _ _ |a DZNE-2021-00989
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Netea, Mihai G
|b 0
245 _ _ |a Author Correction: A guiding map for inflammation.
260 _ _ |a London
|c 2021
|b Springer Nature Limited
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1684913354_29133
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a Balkwill, Frances
|b 1
700 1 _ |a Chonchol, Michel
|b 2
700 1 _ |a Cominelli, Fabio
|b 3
700 1 _ |a Donath, Marc Y
|b 4
700 1 _ |a Giamarellos-Bourboulis, Evangelos J
|0 0000-0003-4713-3911
|b 5
700 1 _ |a Golenbock, Douglas
|0 P:(DE-2719)9001335
|b 6
|u dzne
700 1 _ |a Gresnigt, Mark S
|0 0000-0002-9514-4634
|b 7
700 1 _ |a Heneka, Michael T
|0 P:(DE-2719)2000008
|b 8
|u dzne
700 1 _ |a Hoffman, Hal M
|b 9
700 1 _ |a Hotchkiss, Richard
|b 10
700 1 _ |a Joosten, Leo A B
|b 11
700 1 _ |a Kastner, Daniel L
|b 12
700 1 _ |a Korte, Martin
|b 13
700 1 _ |a Latz, Eicke
|0 P:(DE-2719)2000062
|b 14
|u dzne
700 1 _ |a Libby, Peter
|b 15
700 1 _ |a Mandrup-Poulsen, Thomas
|b 16
700 1 _ |a Mantovani, Alberto
|0 0000-0001-5578-236X
|b 17
700 1 _ |a Mills, Kingston H G
|b 18
700 1 _ |a Nowak, Kristen L
|b 19
700 1 _ |a O'Neill, Luke A
|b 20
700 1 _ |a Pickkers, Peter
|b 21
700 1 _ |a van der Poll, Tom
|b 22
700 1 _ |a Ridker, Paul M
|b 23
700 1 _ |a Schalkwijk, Joost
|b 24
700 1 _ |a Schwartz, David A
|b 25
700 1 _ |a Siegmund, Britta
|b 26
700 1 _ |a Steer, Clifford J
|b 27
700 1 _ |a Tilg, Herbert
|b 28
700 1 _ |a van der Meer, Jos W M
|b 29
700 1 _ |a van de Veerdonk, Frank L
|b 30
700 1 _ |a Dinarello, Charles A
|b 31
773 _ _ |a 10.1038/s41590-020-00846-5
|g Vol. 22, no. 2, p. 254 - 254
|0 PERI:(DE-600)2026412-4
|n 2
|p 254 - 254
|t Nature immunology
|v 22
|y 2021
|x 1529-2916
787 0 _ |a Netea, Mihai G et.al.
|d New York, NY : Nature America Inc., 2017
|i RelatedTo
|0 DZNE-2020-05716
|r
|t A guiding map for inflammation.
856 4 _ |u https://pub.dzne.de/record/155829/files/DZNE-2021-00989_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/155829/files/DZNE-2021-00989_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:155829
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 6
|6 P:(DE-2719)9001335
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2000008
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2000062
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-03-30
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT IMMUNOL : 2021
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-03-30
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-03-30
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT IMMUNOL : 2021
|d 2023-03-30
920 1 _ |0 I:(DE-2719)1013024
|k AG Latz
|l Innate Immunity in Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1011301
|k AG Heneka 1
|l Interventional Trials and Biomarkers in Neurodegenerative Diseases
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013024
980 _ _ |a I:(DE-2719)1011301
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21